Seth Lerner, MD, FACS

Seth Lerner, MD, FACS, Baylor College of Medicine

Articles by Seth Lerner, MD, FACS

VTP for Low-Grade UTUC, NAC for cN+ Disease

Seth Lerner, MD, FACSUpper Tract Urothelial Carcinoma | May 21, 2024

Dr. Lerner shares updates from the ENLIGHTED trial and analyses pertaining to NAC for UTUC from the ROBUUST registry.

ENVISION: UGN-102 and Chemoablation for Low-Grade, Intermediate-Risk NMIBC

Seth Lerner, MD, FACSNon-Muscle Invasive Urothelial Carcinoma | December 18, 2023

Dr. Lerner shares his thoughts on the results of ENVISION and the potential for UGN-102 for lg/ir NMIBC.

Standard Versus Extended Lymph Node Dissection At Time of Cystectomy for MIBC

Seth Lerner, MD, FACSMuscle Invasive Urothelial Carcinoma | December 18, 2023

Dr. Lerner explains what the SWOG S1011 study suggests about the outcomes benefit of standard versus extended LND for MIBC.

Drs. Lerner, Koshkin on SWOG S1011 Results for Lymphadenectomy for Metastatic Urothelial Carcinoma

Seth Lerner, MD, FACSASCO 2023 | June 20, 2023

Drs. Lerner and Koshkin explain the implications of the latest data from the SWOG S1011 study for mUC.